You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Correction: Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy

Article metrics

Article menu

See original article:

Download PDFPDF

XML
Correction
Correction: Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy

 

Online download statistics by month:

Online download statistics by month: September 2020 to August 2025

AbstractFullPdf
Sep 2020013859
Oct 202004424
Nov 20200279
Dec 20200196
Jan 20210318
Feb 20210218
Mar 202101812
Apr 20210174
May 2021035
Jun 20210163
Jul 20210107
Aug 20210118
Sep 2021086
Oct 202101717
Nov 20210819
Dec 2021083
Jan 20220165
Feb 2022074
Mar 202201611
Apr 20220215
May 20220228
Jun 202202911
Jul 20220202
Aug 20220254
Sep 20220177
Oct 202201510
Nov 20220135
Dec 2022083
Jan 2023075
Feb 20230385
Mar 2023072
Apr 2023046
May 2023062
Jun 2023053
Jul 2023099
Aug 2023028
Sep 2023072
Oct 2023051
Nov 20230111
Dec 20230140
Jan 2024092
Feb 20240112
Mar 20240747
Apr 2024066
May 2024062
Jun 20240123
Jul 20240194
Aug 2024052
Sep 2024092
Oct 2024085
Nov 20240122
Dec 20240121
Jan 20250153
Feb 20250123
Mar 2025096
Apr 20250293
May 2025033
Jun 20250173
Jul 2025010
Aug 2025010
Total0923416